Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Frédéric Galactéros, MDPhD, Ersi Voskaridou, Anoosha Habibi, MD PhD, Giovanna Cannas, MD, Laure Joseph, MD, Gylna Loko, MD, Mariane De Montalembert, MD PhD, Narcisse Elenga, MD PhD, Malika Benkerrou, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140265

Published: 2020

Journal Articles

Persistance of Inflammatory Phenotype of Neutrophils in Sickle Cell Disease Children Despite Chronic Exchange Transfusion Program: A Cause of the Progression of Cerebral Vasculopathy?

Abdoul Karim Dembele, MD, Patricia Hermand-Tournamille, PhD, Florence Missud, MD, Emmanuelle Lesprit, MD, Malika Benkerrou, MD, Yves Colin Aronovicz, PhD, Caroline Le Van Kim, PhD, Bérengère Koehl, MDPhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136098

Published: 2020

Journal Articles

Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France

Valentine Brousse, MD PhD, Cécile Arnaud, MD, Emmanuelle Lesprit, MD, Marie-Helene Odièvre-Montanié, MD PhD, Maryse Etienne-Julan, MD, Gisele Elana, MD, Marie Belloy, MD, Cecile Dumesnil, MD, Beatrice Quinet, MD, Abdourahim Chamouine, MD, Cecile Guillaumat, MD, Nathalie Garnier, MD, Corinne Pondarré, MD PhD, Nathalie Couque, PharmD, Francoise Bernaudin, MD, Mariane de Montalembert, MD PhD, Emmanuelle Boutin, MD, Malika Benkerrou, MD, Isabelle Thuret, MD

Blood (2019) 134 (Supplement_1): 1001.

https://doi.org/10.1182/blood-2019-127221

Published: 2019

Journal Articles

Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occlusive Crises in Routine Practice

Ersi Voskaridou, MD, Lena Oevermann, MD, Corinne Armari-Alla, MD, Uwe Kordes, MD MRCP, Frédéric Galactéros, MDPhD, Malika Benkerrou, MD, Isabelle Thuret, MD, Dominique Steschenko, MD

Blood (2018) 132 (Supplement 1): 855.

https://doi.org/10.1182/blood-2018-99-116040

Published: 2018

Journal Articles

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Lena Oevermann, MD, Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Marie Petras, MD, Marie Belloy, MD, Narcisse Elenga, MD PhD

Blood (2018) 132 (Supplement 1): 1079.

https://doi.org/10.1182/blood-2018-99-114441

Published: 2018

Journal Articles

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Frédéric Galactéros, MDPhD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD, Corinne Pondarré, MD PhD, Jean Benoît Arlet, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Lena Oevermann, MD, Stephan Lobitz, MD

Blood (2017) 130 (Supplement 1): 3543.

https://doi.org/10.1182/blood.V130.Suppl_1.3543.3543

Published: 2017

Journal Articles

Management of Renal Dysfunctions in Escort-HU Study

Pablo Bartolucci, MD PhD, Gylna Loko, MD, Corinne Charneau, MD, Jean-Antoine Ribeil, MD, Nathalie Lemonne, MD, Stephan Lobitz, MD, Malika Benkerrou, MD, Frederic Galacteros, MDPhD

Blood (2017) 130 (Supplement 1): 3528.

https://doi.org/10.1182/blood.V130.Suppl_1.3528.3528

Published: 2017

Journal Articles

Off-Label Prescription of Hydroxycarbamide (Hydroxyurea, HU) for Severe Anemia: Preliminary Results from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Mariane De Montalembert, MD PhD, Gylna Loko, MD, Jerome Clouzeau, MD, Valentine Brousse, MD, Frederic Galacteros, MDPhD, Corinne Charneau, MD, Marie Belloy, MD, Malika Benkerrou, MD

Blood (2017) 130 (Supplement 1): 758.

https://doi.org/10.1182/blood.V130.Suppl_1.758.758

Published: 2017

Journal Articles

Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease

Bérengère Koehl, MD PhD, Elsa Maksoud, engineer, Phuong Ha, engineer, Wei Zhao, engineer, Florentia Kaguelidou, MD PhD, Malika Benkerrou, MD, Patricia Mariani, MD, Mathie Lorrot, MD PhD, Albert Faye, MD PhD, Evelyne Jacqz-Aigrain, MD PhD, Andre Baruchel, MD

Blood (2017) 130 (Supplement 1): 975.

https://doi.org/10.1182/blood.V130.Suppl_1.975.975

Published: 2017

Journal Articles

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Regine Grosse, MD, Uwe Kordes, MD MRCP, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Corinne Armari-alla, MD, Narcisse Elenga, MD, Marcin Wlodarski, MD, Stephan Lobitz, MD

Blood (2016) 128 (22): 2494.

https://doi.org/10.1182/blood.V128.22.2494.2494

Published: 2016

Journal Articles

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Ersi Voskaridou, MD, Stephan Lobitz, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD PhD, Frederic Galacteros, MD PhD

Blood (2016) 128 (22): 2497.

https://doi.org/10.1182/blood.V128.22.2497.2497

Published: 2016

Journal Articles

The Endothelin Receptor Etb Plays a Crucial Role for Recruitment of Neutrophils to the Vascular Wall in Sickle Cell Disease

Bérengere Koehl, MD, Pierre Nivoit, PhD, Wassim El Nemer, PhD, Catia Pereira, Valentine Brousse, MD, Lea Guyonnet, Anna Chipont, Olivia Lenoir, Malika Benkerrou, MD, Yves Colin Aronovicz, PhD, Pierre-Louis Tharaux, Caroline Le Van Kim, PhD

Blood (2016) 128 (22): 857.

https://doi.org/10.1182/blood.V128.22.857.857

Published: 2016

Journal Articles

Risk Factors for Cerebral Vasculopathy in a Sickle Cell Disease Neonatal Cohort: A Prospective Study

Julie Sommet, MD, Corinne Alberti, MD PhD, Nathalie Couque, PhD, Zinedine Haouari, MD, Florence Missud, MD, Laurent Holvoet, MD, Ghislaine Ithier, MD, André Baruchel, MD, Malika Benkerrou, MD

Blood (2014) 124 (21): 4098.

https://doi.org/10.1182/blood.V124.21.4098.4098

Published: 2014

Journal Articles

Risk Factors For Cerebral Vasculopathy In a Sickle Cell Disease Newborn Cohort

Julie Sommet, MD, Corinne Alberti, MD, PhD, Laurent Holvoet, MD, Zinedine Haouari, MD, Florence Missud, MD, Ghislaine Ithier, MD, Suzanne Verlhac, MD, Monique Elmaleh, MD, Andre Baruchel, MD, PhD, Malika Benkerrou, MD

Blood (2013) 122 (21): 4685.

https://doi.org/10.1182/blood.V122.21.4685.4685

Published: 2013

Journal Articles

Development of Psycho-Intellectual Performances of Transplanted Sickle Cell Disease Patients: a Prospective Study From Pre-Transplant Period to 5 Years After HSCT.

Jacqueline Bockenmeyer, PhD, Karima Yakouben, Dalila Adjaoud, Brigitte Lescoeur, MD, Marie Ouachée-Chardin, MD, Malika Benkerrou, MD, Jean-Hugues Dalle, MD, PhD, Andre Baruchel, MD

Blood (2009) 114 (22): 522.

https://doi.org/10.1182/blood.V114.22.522.522

Published: 2009

NARROW

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Persistance of Inflammatory Phenotype of Neutrophils in Sickle Cell Disease Children Despite Chronic Exchange Transfusion Program: A Cause of the Progression of Cerebral Vasculopathy?

Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France

Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occlusive Crises in Routine Practice

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Management of Renal Dysfunctions in Escort-HU Study

Off-Label Prescription of Hydroxycarbamide (Hydroxyurea, HU) for Severe Anemia: Preliminary Results from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

The Endothelin Receptor Etb Plays a Crucial Role for Recruitment of Neutrophils to the Vascular Wall in Sickle Cell Disease

Risk Factors for Cerebral Vasculopathy in a Sickle Cell Disease Neonatal Cohort: A Prospective Study

Risk Factors For Cerebral Vasculopathy In a Sickle Cell Disease Newborn Cohort

Development of Psycho-Intellectual Performances of Transplanted Sickle Cell Disease Patients: a Prospective Study From Pre-Transplant Period to 5 Years After HSCT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only